• Latest Posts

Five advancements in brain tumor research over the past year

67% five-year survival rate in glioblastoma therapy, according to CANbridge Pharmaceuticals study

Enterome completes patient enrollment for recurrent glioblastoma study

NW Bio reports positive top-line results from phase 3 glioblastoma trial

Healthy volunteer study for tablet to treat brain cancer open for recruitment


License from Helmholtz Munich will enable progression of brain cancer treatment